CrossrefInfokarte
Absorption, distribution, metabolism, excretion, and pharmacokinetics of remibrutinib, an oral, highly selective Bruton tyrosine kinase inhibitor, in healthy participants at steady state
Drug Metabolism and Disposition · 2026-11 · 54 (11) · 100417
DOI: 10.1016/j.dmd.2026.100417 ↗Abstract
Kein Abstract verfügbar.
EUVIMED